SHOKLO MALARIA RESEARCH UNIT
🇹🇭Thailand
- Country
- 🇹🇭Thailand
- Ownership
- -
- Established
- 1986-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.shoklo-unit.com/
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)Vivax Elimination With Tafenoquine (VET) Study
Phase 4
Active, not recruiting
- Conditions
- Malaria, VivaxPlasmodium VivaxPlasmodium Vivax MalariaMalaria
- Interventions
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Shoklo Malaria Research Unit
- Target Recruit Count
- 1000
- Registration Number
- NCT06575647
- Locations
- 🇹🇭
Shoklo Malaria Research Unit (SMRU), Mae Sot, Tak Province, Thailand
ACT vs CQ With Tafenoquine for P. Vivax Mono-infection
Phase 4
Recruiting
- Conditions
- Malaria, VivaxMalariaPlasmodium Vivax Malaria
- Interventions
- Drug: Artemether-Lumefantrine plus Tafenoquine (450 mg adult dose)Drug: Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
- First Posted Date
- 2023-03-28
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Shoklo Malaria Research Unit
- Target Recruit Count
- 606
- Registration Number
- NCT05788094
- Locations
- 🇹🇭
Shoklo Malaria Research Unit (SMRU), Mae Sot, Tak, Thailand
News
No news found